Mitsubishi UFJ Trust & Banking Corp Sells 14,700 Shares of Zoetis Inc. $ZTS

Key Points

• Mitsubishi UFJ Trust & Banking Corp. reduced its Zoetis stake by 6.4%, selling 14,700 shares and retaining 213,961 shares valued at approximately $15.4 million. Institutional investors collectively own 92.8% of the company.
• Analyst sentiment is mixed but leans cautious: Zoetis has a consensus “Hold” rating and a $109.62 average price target, while several brokerages recently cut their targets.
• Zoetis beat quarterly earnings expectations with $1.87 in EPS, though revenue declined slightly year over year. Shares opened at $73.64, near their 52-week low, and the company declared a quarterly dividend of $0.53 per share.

Mitsubishi UFJ Trust & Banking Corp cut its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 6.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 213,961 shares of the company's stock after selling 14,700 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp owned about 0.05% of Zoetis worth $15,375,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ZTS. Brighton Jones LLC raised its holdings in shares of Zoetis by 180.4% during the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock valued at $754,000 after purchasing an additional 2,978 shares in the last quarter. Empowered Funds LLC boosted its holdings in Zoetis by 6.2% in the first quarter. Empowered Funds LLC now owns 11,293 shares of the company's stock worth $1,859,000 after purchasing an additional 657 shares in the last quarter. Intech Investment Management LLC boosted its holdings in Zoetis by 17.2% in the first quarter. Intech Investment Management LLC now owns 8,347 shares of the company's stock worth $1,374,000 after purchasing an additional 1,224 shares in the last quarter. Sivia Capital Partners LLC increased its position in Zoetis by 73.8% during the second quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company's stock worth $522,000 after buying an additional 1,422 shares during the last quarter. Finally, Glenview Trust co raised its holdings in Zoetis by 11.8% during the second quarter. Glenview Trust co now owns 4,780 shares of the company's stock valued at $745,000 after buying an additional 506 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ZTS. UBS Group reduced their price target on Zoetis from $85.00 to $80.00 and set a "neutral" rating for the company in a research report on Friday, August 7th. HSBC lowered their price objective on Zoetis from $140.00 to $95.00 and set a "buy" rating on the stock in a report on Monday, July 6th. Wall Street Zen downgraded Zoetis from a "buy" rating to a "hold" rating in a research note on Saturday, May 2nd. Piper Sandler reduced their target price on Zoetis from $90.00 to $80.00 and set a "neutral" rating for the company in a report on Monday, August 10th. Finally, Barclays decreased their target price on Zoetis from $136.00 to $85.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 1st. Eight investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Zoetis has a consensus rating of "Hold" and a consensus target price of $109.62.

Zoetis Price Performance

Shares of NYSE:ZTS opened at $73.64 on Friday. The firm has a market capitalization of $30.43 billion, a PE ratio of 12.13, a PEG ratio of 1.28 and a beta of 0.74. The company has a current ratio of 3.08, a quick ratio of 1.84 and a debt-to-equity ratio of 2.87. Zoetis Inc. has a 1-year low of $71.45 and a 1-year high of $160.48. The business's 50 day moving average is $76.30 and its 200-day moving average is $99.01.

Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $1.87 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.02. The business had revenue of $2.47 billion during the quarter, compared to analyst estimates of $2.50 billion. Zoetis had a return on equity of 74.89% and a net margin of 27.49%.Zoetis's revenue was down .2% on a year-over-year basis. During the same period in the prior year, the company posted $1.76 earnings per share. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. Sell-side analysts predict that Zoetis Inc. will post 6.19 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Monday, July 20th. Zoetis's payout ratio is 34.93%.

About Zoetis

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source